Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 2Unknown 1

Sponsor Class

INDUSTRY 8NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Gynecologic 1

Conditions

Anemia 2Uterine Cervical Neoplasms 1Fatigue 1

Interventions

Cyclophosphamide 178Radiotherapy 147Paclitaxel 128Carboplatin 124Bevacizumab 123Cisplatin 119Doxorubicin 111Fluorouracil 107Etoposide 102Filgrastim 99Vincristine 88Leucovorin 82Bortezomib 80Gemcitabine 76aldesleukin 74Sorafenib 70Cytarabine 70Taxes 69fludarabine phosphate 67Irinotecan 66Docetaxel 64Oxaliplatin 60sargramostim 58Sirolimus 58temsirolimus 56Erlotinib Hydrochloride 56Methotrexate 55Rituximab 54Vorinostat 52Radiation 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × NIH × epoetin beta × Clear all
NCT00046969 2013-05-30

Epoetin Beta in Treating Anemia in Patients With Cervical Cancer

National Cancer Institute (NCI)

Phase 4 Completed
450 enrolled
Classical hematologyGynecologic

Anemia, Uterine Cervical Neoplasms

NCT00559195 2011-05-16

Epoetin Beta in Treating Fatigue and Anemia in Patients Receiving Palliative Care for Malignant Solid Tumors

National Cancer Institute (NCI)

Phase 2 Completed
40 enrolled
Classical hematology

Anemia, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡